Anti-pollution Effects of AP Green Tea Extracts
- Conditions
- Respiratory Conditions Due to Unspecified External Agent
- Interventions
- Dietary Supplement: AP green tea extracts
- Registration Number
- NCT04340375
- Lead Sponsor
- Amorepacific Corporation
- Brief Summary
The objective of this clinical trial is to evaluate the anti-pollution effects of AP green tea extracts in subjects with discomforts related to the respiratory system by prolonged exposure to particulate matter in air pollution
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Subjects aged 19 years or over
- Subjects with discomforts related to the respiratory system by prolonged exposure to particulate matter in air pollution
- Subjects who voluntarily decide to participate in this clinical study and sign the informed consent form on their own or through their representatives
- At the screening visit, subjects who were diagnosed with acute or chronic respiratory disease and undergoing medication.
- Subjects who were diagnosed with ventricular associated disease, unstable and uncontrolled chronic medical disease, or active malignant tumor and undergoing medication within 4 weeks prior to the first administration of the investigational product
- Subjects who show a level of ALT/AST of 2 times or more the upper limit of normal as a result of a screening test and have acute or chronic hepatitis or known liver cirrhosis
- In addition to the above, subjects who are determined to be ineligible to participate in the clinical study according to the investigator's medical opinion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description AP green tea extracts AP green tea extracts 8 weeks
- Primary Outcome Measures
Name Time Method Pulmonary function test 8 weeks Improvement in pulmonary function test
Heavy metals 8 weeks Blood concentration of heavy metals
Respiratory health survey 8 weeks Patients' self evaluation of COPD Assessment Test
Biomarkers 8 weeks Blood concentration of biomarkers (Inflammatory cytokines)
- Secondary Outcome Measures
Name Time Method Bronchial assessment 8 weeks Patients' self evaluation of Bronchiectasis Health Questionnaire
Trial Locations
- Locations (1)
Hanyang University Seoul Hospital
🇰🇷Seoul, Korea, Republic of